BRAINTREE, Mass., July 27, 2015 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today reported first quarter fiscal 2016 revenue of $213.4 million, down 5%. Revenue declined 2% in constant currency in the quarter.
The Company reported a GAAP net loss of $0.3 million and a GAAP net loss per share of $0.01 in the quarter. Exclusive of transformation, restructuring and deal amortization expenses detailed below, adjusted net income was $18.0 million and adjusted earnings per share were $0.35, both down 9%.1
Help employers find you! Check out all the jobs and post your resume.
The Company reported a GAAP net loss of $0.3 million and a GAAP net loss per share of $0.01 in the quarter. Exclusive of transformation, restructuring and deal amortization expenses detailed below, adjusted net income was $18.0 million and adjusted earnings per share were $0.35, both down 9%.1
Help employers find you! Check out all the jobs and post your resume.
